These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 36263478)

  • 1. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of key bacteriophages to formulate the potential biocontrol agent to combat enteric pathogenic bacteria.
    Parmar KM; Dafale NA; Tikariha H; Purohit HJ
    Arch Microbiol; 2018 May; 200(4):611-622. PubMed ID: 29330592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pyogenes Φ1207.3 Is a Temperate Bacteriophage Carrying the Macrolide Resistance Gene Pair
    Santoro F; Pastore G; Fox V; Petit MA; Iannelli F; Pozzi G
    Microbiol Spectr; 2023 Feb; 11(1):e0421122. PubMed ID: 36625667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the field of phage-based therapy with special emphasis on computational resources.
    Bajiya N; Dhall A; Aggarwal S; Raghava GPS
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36575815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
    Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
    [No Abstract]   [Full Text] [Related]  

  • 9. Phage-Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against
    Topka-Bielecka G; Nejman-Faleńczyk B; Bloch S; Dydecka A; Necel A; Węgrzyn A; Węgrzyn G
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33669643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Sequencing of High-Efficiency Transducing Streptococcal Bacteriophage A25: Consequences of Escape from Lysogeny.
    McCullor K; Postoak B; Rahman M; King C; McShan WM
    J Bacteriol; 2018 Dec; 200(23):. PubMed ID: 30224437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization of three bacteriophages targeting multidrug resistant clinical isolates of Escherichia, Klebsiella and Salmonella.
    Nepal R; Houtak G; Karki S; Dhungana G; Vreugde S; Malla R
    Arch Microbiol; 2022 May; 204(6):334. PubMed ID: 35585249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacturing of bacteriophages for therapeutic applications.
    João J; Lampreia J; Prazeres DMF; Azevedo AM
    Biotechnol Adv; 2021; 49():107758. PubMed ID: 33895333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia contaminans Bacteriophage CSP3 Requires O-Antigen Polysaccharides for Infection.
    Stanton CR; Batinovic S; Petrovski S
    Microbiol Spectr; 2023 Jun; 11(3):e0533222. PubMed ID: 37199610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomics-Driven Characterization of LUZ100, a T7-like Pseudomonas Phage with Temperate Features.
    Putzeys L; Poppeliers J; Boon M; Lood C; Vallino M; Lavigne R
    mSystems; 2023 Apr; 8(2):e0118922. PubMed ID: 36794936
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding and Exploiting Phage-Host Interactions.
    Stone E; Campbell K; Grant I; McAuliffe O
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31216787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.